Work

Real-world persistence and adherence to relugolix (REL) in US patients with nonmetastatic (nm) vs metastatic (m) prostate cancer (PC).

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.5_suppl.88

Authors: Rana R. McKay, Agnes Hong, Juan Felipe Razo, Scott C Flanders, Christine Ferro, Mila Shapoval, Benjamin Li, Stephen J. Freedland

Institutions: University of California San Diego, Moores Cancer Center, Pfizer (United States), Sumitomo Dainippon Pharma (United States), Milliman (United States), Cedars-Sinai Medical Center, Durham VA Medical Center

Language: English

Topic: Medication Adherence and Compliance

Subfield: Family Practice

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4407701260

Cites:

Cited by:

Related to: 10